Walgreen Crunches Numbers from USA Drug Buy

by Arkansas Business Staff  on Monday, Jan. 21, 2013 12:00 am  

According to Walgreen Co.'s earnings report for its fiscal first quarter, which ended Nov. 30, buying USA Drug from Stephen L. LaFrance Holdings Inc. cost Walgreen's $416 million.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access stories older than 20 days.

Purchase Now

Already have archive access? Login to view this article.